Study of adherence to therapy in patients with arterial hypertension and comorbidity

• Aksana Muhamedovna Kardangusheva Head of the Department of Public Health, Health Care and Preventive Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia http://orcid.org/0000-0002-2960-7928
• Inna Fuadovna Pshigotizheva Faculty of Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia. http://orcid.org/0000-0002-7048-4173
• Leila Dadashevna Kardanova Department of General Medical Practice and Medical Rehabilitation Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia http://orcid.org/0000-0003-1570-2497
• Sofiat Khasenovna Sizhazheva Department of Public Health, Health Care and Preventive Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia http://orcid.org/0000-0002-4412-6700
• Svetlana Zaurovna Shigalugova Department of Public Health, Health Care and Preventive Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia http://orcid.org/0000-0003-3128-0861
• Inna Mukhamedovna Dudarova Department of Public Health, Health Care and Preventive Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia http://orcid.org/0000-0002-2684-7301

DOI: https://doi.org/10.46925//rdluz.33.18

Keywords: adherence to therapy; arterial hypertension; cardiovascular diseases; comorbidity

Abstract

The aim of the research is to study the parameters of tolerance and adherence to antihypertensive therapy in patients with arterial hypertension and comorbidity in real clinical practice. Material and methods. The study included 138 adult patients (29% of men and 71% of women) with arterial hypertension and comorbidity receiving therapy in the cardiology department. The average age of the patients was 64.3 ± 12 years. Results. The mean Charlson index in our study was 3.97 ± 2.0 points (3.75 ± 2.3 points for men and 4 ± 1.9 points for women). Treatment adherence was low in 40% of men and 24.5% of women. The lowest rates of adherence were found to medical follow-up (85% in men and 83.6% in women) and lifestyle modifications (80% in men and 77.5% in women), the highest rates of adherence were to drug therapy (20 % for men and 18.4% for women). Significant correlations were found for all adherence categories with age and the number of drugs taken.Conclusion. Adherence to treatment in almost a third of the patients we surveyed was low. The lowest rates of adherence were found to medical support and lifestyle modifications, the highest were found to drug therapy. The factors influencing adherence, efficacy and tolerability of treatment includes age and the number of drugs taken.

References

Chazova, I. Ye. and Zhernakova, Yu. V. [on behalf of the experts] (2019). Clinical guidelines. Diagnostics and treatment of arterial hypertension. Systemic hypertension, 16 (1), 6–31.

Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, Sh., Hofman, A., Mant, J. and Franco, O. H. (2013). Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European Heart Journal, 34, 2940-2948. DOI: 10.1093/eurheartj/eht295

Franklin, S. S., Lopez, V. A., Wong, N. D. et al. (2009). Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation, 119, 243–250.

Ho, P. M., Bryson, C. L. and Rumsfeld, J. S. (2009). Medication adherence: its importance in cardiovascular outcomes. Curculation, 119 (23), 3028-3035. DOI: 10.1161/CIRCULATIONAHA.108.768986

Khokhlov, A. L., Lisenkova, L. A. and Rakov, A. A. (2003). Analysis of factors determining adherence to antihypertensive therapy. Good Clinical Practice, 4, 59-66.

Lukina, Yu. V., Kutishenko, N. P. and Martsevich, S. Yu. (2017). Treatment adherence: a modern perspective on a familiar problem. Cardiovascular Therapy and Prevention, 16 (1), 91–95. DOI: http://dx.doi.org/10.15829/1728-8800-2017-1-91-95

Martsevich, S. Yu., Lukina, Yu. V., Kutishenko, N. P., Voronina, V. P. et al. (2017). Study of the parameters of tolerance and adherence to therapy in patients with chronic obstructive pulmonary disease and arterial hypertension during treatment with a fixed combination of ramipril and amlodipine (according to the results of the observational study "GRANAT-2"). Rational pharmacotherapy in cardiology, 13. DOI: http://dx.doi.org/10.20996/1819-6446-2017-13-2-XX-XX National recommendations of the Russian Scientific Medical Society of Physicians for the quantitative assessment of adherence to treatment (2017). Moscow, 24.

Oganov, R. G., Denisov, I. N., Simanenkov, V. I., Bakulin, I. G. et al. (2017). Comorbid pathology in clinical practice. Clinical guidelines. Cardiovascular therapy and prevention, 16 (6), 5-56. DOI: 10.15829 / 1728-8800-2017-6-5-56

Osterberg, L. and Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353, 487-497.

Williams, B., Mancia, G., Spiering, W. et al. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension, 36 (10), 1953–2041.

World Health Organization. Adherence to long-term therapies: evidence for action (2003). WHO Library Cataloguing-in-Publication Data, Geneva, WHO, 211.